Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by BackTable Inc.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BackTable Inc. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep. 527 Managing Hereditary Hemorrhagic Telangiectasia and Pulmonary AVMs with Dr. Clifford Weiss

26:07
 
Share
 

Manage episode 472570489 series 2658136
Content provided by BackTable Inc.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BackTable Inc. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Targeted, image-guided interventions can make a big difference for patients with hereditary hemorrhagic telangiectasia (HHT). Learn how in this week’s BackTable episode featuring Dr. Clifford R. Weiss (Director of the Johns Hopkins Vascular Anomalies Center and HHT Center of Excellence) and host Dr. Michael Barraza.

---

SYNPOSIS

Dr. Weiss delves into the complexities and multisystem nature of HHT, emphasizing the significance of early diagnosis and multidisciplinary care. He goes on to explain the clinical criteria for diagnosing HHT, the role of genetic and imaging screenings, and the evolving approaches to treating pulmonary arteriovenous malformations (AVMs) in adults and children. The doctors discuss the potential impact of anti-angiogenic medications on the future management of HHT. The episode closes with a nod to the pivotal role that HHT Centers of Excellence play, and the ongoing dedication to improving patient outcomes through collaborative care and innovative research.

---

TIMESTAMPS

00:00 - Introduction

03:57 - Diagnosing and Screening for Hereditary Hemorrhagic Telangiectasia (HHT)

07:37 - Treatment Approaches for HHT

12:12 - Embolization Techniques and Safety Measures

19:02 - Future of HHT Treatment and Research

22:30 - Conclusion and Final Thoughts

---

RESOURCES

The Johns Hopkins Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence:

https://www.hopkinsmedicine.org/interventional-radiology/hht

  continue reading

551 episodes

Artwork
iconShare
 
Manage episode 472570489 series 2658136
Content provided by BackTable Inc.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BackTable Inc. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Targeted, image-guided interventions can make a big difference for patients with hereditary hemorrhagic telangiectasia (HHT). Learn how in this week’s BackTable episode featuring Dr. Clifford R. Weiss (Director of the Johns Hopkins Vascular Anomalies Center and HHT Center of Excellence) and host Dr. Michael Barraza.

---

SYNPOSIS

Dr. Weiss delves into the complexities and multisystem nature of HHT, emphasizing the significance of early diagnosis and multidisciplinary care. He goes on to explain the clinical criteria for diagnosing HHT, the role of genetic and imaging screenings, and the evolving approaches to treating pulmonary arteriovenous malformations (AVMs) in adults and children. The doctors discuss the potential impact of anti-angiogenic medications on the future management of HHT. The episode closes with a nod to the pivotal role that HHT Centers of Excellence play, and the ongoing dedication to improving patient outcomes through collaborative care and innovative research.

---

TIMESTAMPS

00:00 - Introduction

03:57 - Diagnosing and Screening for Hereditary Hemorrhagic Telangiectasia (HHT)

07:37 - Treatment Approaches for HHT

12:12 - Embolization Techniques and Safety Measures

19:02 - Future of HHT Treatment and Research

22:30 - Conclusion and Final Thoughts

---

RESOURCES

The Johns Hopkins Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence:

https://www.hopkinsmedicine.org/interventional-radiology/hht

  continue reading

551 episodes

すべてのエピソード

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play